The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Valproic acid
Abstract
Valproic acid use during pregnancy results in an absolute risk for spina bifida of 1–2%. This increased risk is comparable to the recurrence risk for neural tube defects and warrants informed counselling and access to prenatal diagnosis. There is no substantial evidence that valproic acid use increases the risk for other specific major malformations above the increased risk due to maternal epilepsy. Valproic acid may cause a characteristic pattern of minor facial malformations. Further definition and confirmation are required, and the magnitude of the risk needs to be determined. There are inadequate data to assess the magnitude, if any, of the risks for postnatal growth abnormalities and developmental disabilities associated with the use of valproic acid during pregnancy. Birth‐defect monitoring programs and international collaboration among the staffs of monitoring programs played a major role in determining that valproic acid is a human teratogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTS
Robert, E., & Guibaud, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90908-4 · Cited by 539
DiLiberti, J. H., Farndon, P. A., Dennis, N. R., & Curry, C. J. R. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320190308 · Cited by 399
Sodium Valproate: A Review of its Pharmacological Properties and Therapeutic Efficacy in Epilepsy
Pinder, R. M., Brogden, R. N., Speight, T. M., & Avery, G. S. (1977) · Drugs · doi:10.2165/00003495-197713020-00001 · Cited by 315
Nakane, Y., Okuma, T., Takahashi, R., Sato, Y., Wada, T., Sato, T., Fukushima, Y., Kumashiro, H., Ono, T., Takahashi, T., et al. (1980) · Epilepsia · doi:10.1111/j.1528-1157.1980.tb04320.x · Cited by 301
VALPROIC ACID AND SPINA BIFIDA
Bjerkedal, T., Czeizel, A., Goujard, J., Kallen, B., Mastroiacova, P., Nevin, N., Oakley, G., & Robert, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90018-6 · Cited by 265
Self-citationFETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGS
Hiilesmaa, V. K., Teramo, K., Granström, M.-L., & Bardy, A. H. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90354-8 · Cited by 167
Koch-Weser, J., & Browne, T. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198003203021204 · Cited by 167
Nau, H., Zierer, R., Spielmann, H., Neubert, D., & Gansau, C. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90541-5 · Cited by 166
Epilepsy, pregnancy and the child
Hughes, J. R. (1982) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(82)90053-0 · Cited by 165
Teratogenicity of valproic acid: In vivo and in vitro investigations
Kao, J., Brown, N. A., Schmid, B., Goulding, E. H., & Fabro, S. (1981) · Teratogenesis, Carcinogenesis, and Mutagenesis · doi:10.1002/tcm.1770010405 · Cited by 161
Teratogenicity of valproic acid
Dalens, B. J., Raynaud, E., & Gaulme, J. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80517-8 · Cited by 154
Valproic Acid and Metabolites: Pharmacological and Toxicological Studies
Nau, H., & Löscher, W. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb05632.x · Cited by 144
SPINA BIFIDA AND IN-UTERO EXPOSURE TO VALPROATE
Lindhout, D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90557-9 · Cited by 130
Robert, E., & Rosa, F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90656-6 · Cited by 121
Nau, H., Helge, H., & Luck, W. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80567-3 · Cited by 109
Possible teratogenicity of valproic acid
Gómez, M. R. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80743-3 · Cited by 100
Fabro, S. E., Shull, G. E., & Brown, N. A. (1982) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/1520-6866(1990)2:1<61::aid-tcm1770020107>3.0.co;2-o · Cited by 96
Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture
Bruckner, A., Lee, Y. J., O’Shea, K. S., et al. (1983) · Teratology · doi:10.1002/tera.1420270106 · Cited by 96
Löscher, W., Nau, H., Marescaux, C., & Vergnes, M. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90243-7 · Cited by 95
TERATOGENIC POTENTIAL OF VALPROIC ACID
Brown, N., Kao, J., & Fabro, S. E. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91159-9 · Cited by 84
DICKINSON, R. G., Harland, R. C., Lynn, R. K., Smith, W. B., & Gerber, N. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80172-9 · Cited by 83
SODIUM VALPROATE AND NEURAL TUBE DEFECTS
Stanley, O., Chambers, T. L., Jeavons, P. M., & MacRae, K. D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90141-6 · Cited by 71
Teratogenesis of calcium valproate in rats
ONG, L., Schardein, J. L., Petrere, J. A., Sakowski, R., JORDAN, H., HUMPHREY, R., FITZGERALD, J., & DELAIGLESIA, F. (1983) · Fundamental and Applied Toxicology · doi:10.1016/s0272-0590(83)80067-0 · Cited by 67
Possible teratogenic effect of valproate during pregnancy
Koch, S., Jäger‐Roman, E., Rating, D., & Helge, H. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80750-1 · Cited by 46
Possible Valproate Teratogenicity
Tein, I., & MacGregor, D. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060030113019 · Cited by 42
MATERNAL EPILEPSY, VALPROATE EXPOSURE, AND BIRTH DEFECTS
Mastroiacovo, P., Bertollini, R., Morandini, S. R., & Segni, G. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90844-9 · Cited by 41
Valproic Acid and Congenital Malformations
Bantz, M. E. W. (1984) · Clinical Pediatrics · doi:10.1177/000992288402300611 · Cited by 25
VALPROIC ACID DURING PREGNANCY
Hiilesmaa, V., Bardy, A. H., Granström, M.-L., et al. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91387-2 · Cited by 23
Valproate: a new cause of birth defects--report from Italy and follow-up from France.
(1983) · PubMed · Cited by 19
Cited by
Zika Virus and Birth Defects — Reviewing the Evidence for Causality
Rasmussen, S. A., Jamieson, D. J., Honein, M. A., & Petersen, L. R. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1604338 · Cited by 1,989
Drugs in Pregnancy and Lactation
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-902_3 · Cited by 1,075
Botto, L. D., Moore, C. A., Khoury, M. J., & Erickson, J. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911113412006 · Cited by 980
Koren, G., Pastuszak, A., & Ito, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381607 · Cited by 748
Neural tube defects: recent advances, unsolved questions, and controversies
Copp, A. J., Stanier, P., & Greene, N. D. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70110-8 · Cited by 679
Metadata
- Authors
- Lammer, E. J., Sever, L. E., & Oakley, G. P.
- Venue
- Teratology
- Publisher
- Wiley
- Published
- 1987-06
- Volume
- 35
- Issue
- 3
- Pages
- 465-473
- ISSN
- 0040-3709 (ISSN-L)
- 1096-9926
- OpenAlex
- W125743501
- Cited by
- 291
- References
- 29
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.